The researchers used two prostate cancer cell lines, LNCaP and CWR22Rv1 cells, to prove that metformin does not affect the degradation or stability of AR protein; however, it suppresses the AR signaling pathway by repressing AR mRNA expression [30]. This evidence concerns the gene AR and prostate cancer.